BY RATTAN MALL
INDIAN High Commissioner Ajay Bisaria’s positive attitude regarding relations between Canada and India is based on solid facts.
For example, there has been a mind-boggling increase in investments from about $5 billion portfolio investment in 2015 to about $60 billion today between the two countries.
This speaks to the confidence that Canadian investors and portfolio investments and investment firms have in the Indian growth story, notes Bisaria.
An Alberta-based company, Providence Therapeutics, is currently working with Biological E. in India’s Hyderabad to develop an Indo-Canadian vaccine — a messenger RNA [mRNA] vaccine — which is at stage 3 trial.
The Indian government has already reserved 300 million doses of that vaccine.
Bisaria’s diplomatic experience – as you will see in this interview – is amazing. In this…